| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/19/1997 | WO1997021725A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 06/19/1997 | WO1997021710A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | WO1997021709A1 Use of mono- or diketone tetracyclic derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | WO1997021702A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists |
| 06/19/1997 | WO1997021690A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | WO1997021684A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | WO1997021676A1 Azetidinone compounds for the treatment of atherosclerosis |
| 06/19/1997 | WO1997021675A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
| 06/19/1997 | WO1997021670A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 06/19/1997 | WO1997021665A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 06/19/1997 | WO1997021445A1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 06/19/1997 | WO1997021436A1 New use for losartan |
| 06/19/1997 | WO1997021432A1 Use of bicyclic mono- or diketone derivatives, resulting compounds, and use thereof as a drug for treating inflammation, migraine and shock |
| 06/19/1997 | WO1996040098A3 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/19/1997 | DE19546452A1 Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel New Phenylamidinderivate, processes for their Herstelung and their use as medicaments |
| 06/19/1997 | CA2240279A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 06/19/1997 | CA2239908A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 06/19/1997 | CA2238975A1 New use for losartan |
| 06/19/1997 | CA2238711A1 3-benzylaminopyrrolidines and piperidines as tachykinin receptor antagonists |
| 06/19/1997 | CA2238175A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/18/1997 | EP0779288A1 Substituted chromanylsulfonyl(thio)ureas, process for their preparation, their use in pharmaceutical compositions and preparations containing them |
| 06/18/1997 | EP0779279A1 Bicyclic heterocycles |
| 06/18/1997 | EP0779276A1 Indolyl-substituted phenylacetic acid derivatives |
| 06/18/1997 | EP0778851A1 Method for controlling o-desulfation of heparin and compositions produced thereby |
| 06/18/1997 | EP0778846A1 Spirostanyl glycosidal crystals |
| 06/18/1997 | EP0778836A1 Substituted 9-alkyladenines |
| 06/18/1997 | EP0778833A1 Endothelin receptor antagonists |
| 06/18/1997 | EP0778776A1 Hyaluronic acid and derivatives for modulation of cellular activity |
| 06/18/1997 | EP0778772A1 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides |
| 06/18/1997 | EP0687257B1 4-amino-2-(hetero)aryl-butanamides useful as 5-ht1a-antagonists |
| 06/18/1997 | EP0662953B1 Novel vitamin d analogues |
| 06/18/1997 | EP0536363B1 Novel heparin derivatives and process for the preparation thereof |
| 06/18/1997 | EP0494264B1 Inhibiting transforming growth factor to prevent accumulation of extracellular matrix |
| 06/18/1997 | CN1152337A Superoxide dismutase-4 |
| 06/18/1997 | CN1152304A Substituted benzamidines, their production and their use as medicaments |
| 06/18/1997 | CN1152303A Novel chemical compound, its preparation and use as drug |
| 06/18/1997 | CN1151880A Medicine for inflammatory piles |
| 06/17/1997 | US5639904 Cardiovascular disorders |
| 06/17/1997 | US5639872 Human VEGF-specific oligonucleotides |
| 06/17/1997 | US5639855 Adrenomedullin |
| 06/17/1997 | US5639784 Administering 3-amino-5-carbamoyl-chromenes and derivatives |
| 06/17/1997 | US5639783 Ketone derivatives |
| 06/17/1997 | US5639772 Administering 3-amino-5-carbamoyl-chromenes and derivatives for treatment of 5-hydroxytryptamine mediated disorders of central nervous system |
| 06/17/1997 | US5639752 Serotonin agonist |
| 06/17/1997 | US5639736 Reducing neovascularization by administering through the eye |
| 06/17/1997 | US5639727 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/17/1997 | US5639725 Angiostatin protein |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/13/1997 | CA2192518A1 Method for reducing infarct size in subjects afflicted with ischemic heart disease |
| 06/12/1997 | WO1997020845A1 Pyrroloazepine derivatives |
| 06/12/1997 | WO1997020836A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
| 06/12/1997 | WO1997020811A1 Vitamin d analogues |
| 06/12/1997 | WO1997020806A1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| 06/12/1997 | WO1997020805A1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity |
| 06/12/1997 | WO1997020802A1 Indane dimer compounds and their pharmaceutical use |
| 06/12/1997 | WO1997012963A3 A paf-acetylhydrolase and use in therapy |
| 06/12/1997 | CA2212092A1 Pyrroloazepine derivatives |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778274A1 Amidinohydrazones of ketones derived from benzo(b)furan, process for their preparation and medicaments containing these compounds |
| 06/11/1997 | EP0778271A2 Aminoalkyl-substituted benzo-heterocyclic compounds |
| 06/11/1997 | EP0778264A1 Tertiary amines having antimycotic and cholesterol lowering activity |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0777740A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777739A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 06/11/1997 | EP0777689A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777680A1 Urokinase receptor ligands |
| 06/11/1997 | EP0777661A1 Natriuretic and anti-hypertensive compounds |
| 06/11/1997 | EP0777660A1 Novel alkylamino derivatives as sigma 2 selective ligands |
| 06/11/1997 | EP0777653A1 Dihygropyridine derivatives as bradykinin antagonists |
| 06/11/1997 | EP0777652A1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives |
| 06/11/1997 | EP0777646A1 Metalloproteinase inhibitors |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777487A1 Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction |
| 06/11/1997 | EP0777481A1 Use of n-substituted phenothiazines |
| 06/11/1997 | EP0777471A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 06/11/1997 | EP0777469A1 Use of insulin sensitisers for treating renal diseases |
| 06/11/1997 | EP0703913B1 Imidazoles as lipoxygenase inhibitors |
| 06/11/1997 | CN1151729A Aryl and heteroaryl alkoxynaphtalene derivatives |
| 06/11/1997 | CN1151699A Health compsn. |
| 06/11/1997 | CN1151403A Crystals of piperidine derivatives, intermediates for production of same, and process for producing the same |
| 06/11/1997 | CN1151400A Novel sulfonylaminopyrimidines |
| 06/10/1997 | US5637771 Compound useful for lowering cholesterol |
| 06/10/1997 | US5637712 Process of preparing isoquinoline compounds |
| 06/10/1997 | US5637698 Fused multiple ring lactams |
| 06/10/1997 | US5637593 Tryptamine analogues as 5-ht1-like agonists |
| 06/10/1997 | US5637586 Angiotensin inhibitor; hypotensive agent |
| 06/10/1997 | US5637470 Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel |
| 06/09/1997 | CA2190708A1 Aminoalkyl substituted benzo-heterocyclic compounds |
| 06/09/1997 | CA2190699A1 Tertiary amines |
| 06/08/1997 | CA2192044A1 Amidinohydrazones of ketones derived from benzo[b]furan, processes for their production, and pharmaceuticals containing these compounds |
| 06/05/1997 | WO1997019932A1 2-thioxo-imidazolidin-4-one derivatives and their use for increasing hdl cholesterol concentration |
| 06/05/1997 | WO1997019925A1 Quinoline derivatives containing a diol as leukotriene antagonists |
| 06/05/1997 | WO1997019914A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 06/05/1997 | WO1997019697A1 Method of using beta-interferons to treat restenosis |
| 06/05/1997 | WO1997019683A1 Hydrolysis-optimized lipid emulsions and use thereof |
| 06/05/1997 | WO1997019679A2 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |